Recruiting Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers NCT05940272 Conditions DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more Locations Memorial Sloan Kettering Cancer Center (All protocol activities) — New York, United States NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) — New York, United States View Trial Details
Active, Not Recruiting Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL NCT06093841 Conditions Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more Locations Sun Yat-sen University Cancer Hospital — Guangzhou, Guangdong, China Henan Cancer Hospital — Zhengzhou, Henan, China The First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China Hunan Cancer Hospital — Changsha, Hunan, China View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
